Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
| Revenue (Most Recent Fiscal Year) | $23.89B |
| Net Income (Most Recent Fiscal Year) | $4.76B |
| PE Ratio (Current Year Earnings Estimate) | 32.58 |
| PE Ratio (Trailing 12 Months) | 30.79 |
| PEG Ratio (Long Term Growth Estimate) | 3.83 |
| Price to Sales Ratio (Trailing 12 Months) | 7.02 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.45 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 23.48 |
| Pre-Tax Margin (Trailing 12 Months) | 18.27% |
| Net Margin (Trailing 12 Months) | 16.78% |
| Return on Equity (Trailing 12 Months) | 11.43% |
| Return on Assets (Trailing 12 Months) | 7.09% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.85 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.51 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.31 |
| Inventory Turnover (Trailing 12 Months) | 3.45 |
| Book Value per Share (Most Recent Fiscal Quarter) | $72.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.92 |
| Earnings per Share (Most Recent Fiscal Year) | $7.58 |
| Diluted Earnings per Share (Trailing 12 Months) | $5.90 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 740.69M |
| Free Float | 658.47M |
| Market Capitalization | $184.25B |
| Average Volume (Last 20 Days) | 2.86M |
| Beta (Past 60 Months) | 0.83 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 11.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 79.05% |
| Annual Dividend (Based on Last Quarter) | $1.08 |
| Dividend Yield (Based on Last Quarter) | 0.43% |